Statistics for The efficacy and safety of natalizumab for the treatment of multiple sclerosis in Portugal: a retrospective study
Total visits
| views | |
|---|---|
| The efficacy and safety of natalizumab for the treatment of multiple sclerosis in Portugal: a retrospective study | 299 |
Total visits per month
| views | |
|---|---|
| November 2024 | 2 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| The efficacy and safety of natalizumab.pdf(legacy) | 585 |
| Estudio retrospectivo de la eficacia y seguridad del natalizumab.pdf(legacy) | 191 |
| The efficacy and safety of natalizumab.pdf | 6 |
| Estudio retrospectivo de la eficacia y seguridad del natalizumab.pdf | 6 |
Top country views
| views | |
|---|---|
| United States | 141 |
| China | 51 |
| Portugal | 26 |
| Germany | 17 |
| Russia | 16 |
| France | 11 |
| Ukraine | 9 |
| Australia | 3 |
| Norway | 3 |
| Brazil | 2 |
| Canada | 2 |
| Spain | 2 |
| United Kingdom | 2 |
| Singapore | 2 |
| Argentina | 1 |
| Czechia | 1 |
| Hong Kong SAR China | 1 |
| Israel | 1 |
| Iran | 1 |
| Luxembourg | 1 |
| Unknown Region | 1 |